Speakers


Members of the working group

  • Matt Britland, Medical Director, Amgen 
  • Daniela Caiazza, Director Clinical Operations ANZ, Novotech 
  • Jennifer Herz, Founder and Managing Director, Biointelect 
  • Stephen Firmer, Director, Asia Pacific Consultants  
  • Liz Joshi, Director Scientific Affairs, Sandoz ANZ 
  • Steve Kennedy, Vice President Global Regulatory Affairs, Cochlear
  • Ben Laverty, Senior Director, IQVIA 
  • Navinisha Lee, Manager, Drug Safety and Pharmacovigilance Qualified Person for Pharmacovigilance (QPPV), Specialised Therapeutics 
  • Kimberley Lilischkis, Director Clinical Operations, BeiGene 
  • David Spaulding, Partner and Training Manager, SeerPharma 
  • Jacqui Waterkeyn, Associate Director, Regulatory Affairs & Operational Development, Orygen 
  • Karen Whitelock, Pharmacovigilance Head, AbbVie